Results 41 to 50 of about 65 (60)

Evaluation of von Willebrand factor in COPD patients. [PDF]

J Bras Pneumol, 2014
Bártholo TP, Costa CH, Rufino R.
europepmc   +1 more source

Physical activity as a protective factor for development of non-alcoholic fatty liver in men. [PDF]

Einstein (Sao Paulo), 2015
Pinto CG, Marega M, Carvalho JA, Carmona FG, Lopes CE, Ceschini FL, Bocalini DS, Figueira Junior AJ.   +7 more
europepmc   +1 more source

Validation and development of an immunonephelometric assay for the determination of alpha-1 antitrypsin levels in dried blood spots from patients with COPD. [PDF]

J Bras Pneumol, 2013
Zillmer LR, Russo R, Manzano BM, Ivanaga I, Nascimento OA, Souza AA, Santos G, Rodriguez F, Miravitlles M, Jardim JR.   +9 more
europepmc   +1 more source

Los análisis de orina en el diagnóstico de las gammapatías monoclonales: puntos de corte. [PDF]

Adv Lab Med
Vidal-Pla M, Nuez-Zaragoza E, Bhambi I, Aguadero V.   +3 more
europepmc   +1 more source

[Diagnosis by isothermal amplification of nucleic acids. Opportunity for community pharmacies]. [PDF]

Farm Comunitarios
Montero-Gómez A.
europepmc   +1 more source

Evaluación del análisis de la relación albúmina-creatinina mediante tira reactiva como método de cribado para la determinación de albúmina en orina en atención primaria. [PDF]

Adv Lab Med
Liébanas García P, Montolio Breva S, Sans Mateu T.   +2 more
europepmc   +1 more source

Can Pre-Ablation Biomarkers Be Used to Predict Arrhythmia Recurrence after Ablation Index-Guided Atrial Fibrillation Ablation? [PDF]

Arq Bras Cardiol
Palma A, Sousa PA, Saleiro C, Barra S, António N, Adão L, Primo J, Lebreiro A, Fonseca P, Elvas L, Gonçalves L.   +10 more
europepmc   +1 more source